Detailed information for compound 441780

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 600.551 | Formula: C23H22F6N2O6S2
  • H donors: 2 H acceptors: 6 LogP: 4.84 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 2
  • SMILES: CC(C[C@]1(C[C@@H]([C@@H](N1C(=O)c1ccc(cc1)C(F)(F)F)c1cccs1)C(=O)NS(=O)(=O)C(F)(F)F)C(=O)O)C
  • InChi: 1S/C23H22F6N2O6S2/c1-12(2)10-21(20(34)35)11-15(18(32)30-39(36,37)23(27,28)29)17(16-4-3-9-38-16)31(21)19(33)13-5-7-14(8-6-13)22(24,25)26/h3-9,12,15,17H,10-11H2,1-2H3,(H,30,32)(H,34,35)/t15-,17+,21-/m0/s1
  • InChiKey: IDNMVLWIVDJRTG-XPIZARPCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0036 0.1174 0.3351
Plasmodium vivax thioredoxin reductase, putative 0.0029 0.0874 0.2496
Schistosoma mansoni family S12 unassigned peptidase (S12 family) 0.0036 0.1174 0.3351
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0036 0.1174 0.313
Toxoplasma gondii thioredoxin reductase 0.0029 0.0874 0.2496
Toxoplasma gondii LsmAD domain-containing protein 0.0025 0.0674 0.1924
Mycobacterium tuberculosis Probable conserved lipoprotein 0.0036 0.1174 0.1174
Trichomonas vaginalis penicillin-binding protein, putative 0.0036 0.1174 1
Trypanosoma cruzi DNA topoisomerase IB, large subunit, putative 0.0086 0.3503 1
Trichomonas vaginalis phosphofructokinase, putative 0.0013 0.0113 0.0963
Brugia malayi beta-lactamase 0.0036 0.1174 0.3351
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0.1174 0.3351
Mycobacterium leprae conserved hypothetical protein 0.0036 0.1174 1
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.001 0 0.5
Mycobacterium tuberculosis Possible conserved lipoprotein LpqK 0.0036 0.1174 0.1174
Brugia malayi glutathione reductase 0.0029 0.0874 0.2496
Plasmodium vivax hypothetical protein, conserved 0.0036 0.1174 0.3351
Brugia malayi DNA topoisomerase I 0.0086 0.3503 1
Echinococcus granulosus 6 phosphofructokinase 0.0013 0.0113 0.0323
Trypanosoma brucei trypanothione reductase 0.0029 0.0874 0.2496
Schistosoma mansoni hypothetical protein 0.0011 0.0047 0.0133
Mycobacterium tuberculosis Probable esterase LipL 0.0036 0.1174 0.1174
Mycobacterium ulcerans lipase LipD 0.0036 0.1174 1
Echinococcus multilocularis 6 phosphofructokinase 0.0013 0.0113 0.0323
Brugia malayi beta-lactamase family protein 0.0036 0.1174 0.3351
Mycobacterium tuberculosis Probable hydrolase 0.0036 0.1174 0.1174
Plasmodium vivax glutathione reductase, putative 0.0029 0.0874 0.2496
Loa Loa (eye worm) DNA topoisomerase I 0.0086 0.3503 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 0.0674 0.1924
Leishmania major DNA topoisomerase IB, large subunit 0.0086 0.3503 1
Entamoeba histolytica phosphofructokinase, putative 0.0013 0.0113 0.5
Trichomonas vaginalis penicillin-binding protein, putative 0.0036 0.1174 1
Mycobacterium tuberculosis Conserved protein 0.0036 0.1174 0.1174
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 0.0674 0.1924
Plasmodium falciparum topoisomerase I 0.0086 0.3503 1
Trypanosoma brucei ATP-dependent 6-phosphofructokinase, glycosomal 0.0013 0.0113 0.0323
Trypanosoma cruzi ATP-dependent 6-phosphofructokinase, glycosomal 0.0013 0.0113 0.0323
Schistosoma mansoni NAALADASE L peptidase (M28 family) 0.0028 0.084 0.2397
Mycobacterium leprae PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) 0.0013 0.0113 0.0963
Mycobacterium tuberculosis Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) 0.0013 0.0113 0.0113
Loa Loa (eye worm) hypothetical protein 0.0044 0.1574 0.4309
Mycobacterium ulcerans beta-lactamase 0.0036 0.1174 1
Loa Loa (eye worm) thioredoxin reductase 0.0029 0.0874 0.2245
Echinococcus granulosus thioredoxin glutathione reductase 0.0029 0.0874 0.2496
Trichomonas vaginalis phosphofructokinase, putative 0.0013 0.0113 0.0963
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Mycobacterium tuberculosis Probable esterase/lipase LipP 0.0036 0.1174 0.1174
Leishmania major trypanothione reductase 0.0029 0.0874 0.2496
Schistosoma mansoni 6-phosphofructokinase 0.0013 0.0113 0.0323
Mycobacterium tuberculosis Probable lipase LipE 0.0036 0.1174 0.1174
Loa Loa (eye worm) glutathione reductase 0.0029 0.0874 0.2245
Brugia malayi hypothetical protein 0.0025 0.0674 0.1924
Loa Loa (eye worm) beta-lactamase 0.0036 0.1174 0.313
Echinococcus multilocularis Ataxin 2, N terminal,domain containing protein 0.0011 0.0047 0.0133
Entamoeba histolytica phosphofructokinase, putative 0.0013 0.0113 0.5
Echinococcus granulosus Ataxin 2 N terminaldomain containing protein 0.0011 0.0047 0.0133
Onchocerca volvulus 0.0036 0.1174 0.5
Trypanosoma cruzi trypanothione reductase, putative 0.0029 0.0874 0.2496
Trichomonas vaginalis phosphofructokinase, putative 0.0013 0.0113 0.0963
Trypanosoma brucei DNA topoisomerase IB, large subunit 0.0086 0.3503 1
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0.1174 1
Leishmania major hypothetical protein, conserved 0.0025 0.0674 0.1924
Toxoplasma gondii ABC1 family protein 0.0036 0.1174 0.3351
Trichomonas vaginalis esterase, putative 0.0036 0.1174 1
Plasmodium vivax ataxin-2 like protein, putative 0.0025 0.0674 0.1924
Loa Loa (eye worm) hypothetical protein 0.0029 0.0888 0.2287
Echinococcus multilocularis beta LACTamase domain containing family member 0.0036 0.1174 0.3351
Brugia malayi 6-phosphofructokinase 0.0013 0.0113 0.0323
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Mycobacterium tuberculosis Probable lipase LipD 0.0036 0.1174 0.1174
Trypanosoma cruzi PAB1-binding protein , putative 0.0025 0.0674 0.1924
Schistosoma mansoni DNA topoisomerase type I 0.0086 0.3503 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0025 0.0674 0.1924
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0.1174 0.3351
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0.1174 1
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Loa Loa (eye worm) hypothetical protein 0.004 0.1393 0.3775
Entamoeba histolytica phosphofructokinase, putative 0.0013 0.0113 0.5
Trichomonas vaginalis phosphofructokinase, putative 0.0013 0.0113 0.0963
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0036 0.1174 1
Echinococcus granulosus DNA topoisomerase 1 0.0086 0.3503 1
Echinococcus multilocularis n acetylated alpha linked acidic dipeptidase 2 0.0043 0.1525 0.4354
Brugia malayi phosphofructokinase 0.0013 0.0113 0.0323
Giardia lamblia NADH oxidase lateral transfer candidate 0.001 0 0.5
Brugia malayi Thioredoxin reductase 0.0029 0.0874 0.2496
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.001 0 0.5
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0036 0.1174 0.3351
Schistosoma mansoni DNA topoisomerase type I 0.0086 0.3503 1
Schistosoma mansoni DNA topoisomerase type I 0.0086 0.3503 1
Onchocerca volvulus 0.0036 0.1174 0.5
Plasmodium vivax topoisomerase I, putative 0.0086 0.3503 1
Mycobacterium tuberculosis Conserved protein 0.0036 0.1174 0.1174
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.001 0 0.5
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0029 0.0874 0.0874
Onchocerca volvulus 0.0036 0.1174 0.5
Treponema pallidum diphosphate--fructose-6-phosphate 1-phosphotransferase 0.0013 0.0113 1
Trichomonas vaginalis D-aminoacylase, putative 0.0036 0.1174 1
Loa Loa (eye worm) hypothetical protein 0.0025 0.0674 0.1655
Mycobacterium tuberculosis Conserved protein 0.0036 0.1174 0.1174
Mycobacterium ulcerans 6-phosphofructokinase 0.0013 0.0113 0.0963
Brugia malayi 6-phosphofructokinase 0.0013 0.0113 0.0323
Mycobacterium ulcerans hypothetical protein 0.0036 0.1174 1
Echinococcus multilocularis DNA topoisomerase 1 0.0086 0.3503 1
Trypanosoma brucei hypothetical protein, conserved 0.0036 0.1174 0.3351
Brugia malayi beta-lactamase family protein 0.0036 0.1174 0.3351
Schistosoma mansoni 6-phosphofructokinase 0.0013 0.0113 0.0323
Brugia malayi hypothetical protein 0.0016 0.0271 0.0773
Leishmania major ATP-dependent phosphofructokinase 0.0013 0.0113 0.0323
Plasmodium falciparum glutathione reductase 0.0029 0.0874 0.2496
Echinococcus granulosus beta LACTamase domain containing family member 0.0036 0.1174 0.3351
Loa Loa (eye worm) hypothetical protein 0.0036 0.1174 0.313
Toxoplasma gondii DNA topoisomerase I, putative 0.0086 0.3503 1
Leishmania major hypothetical protein, conserved 0.0036 0.1174 0.3351
Echinococcus multilocularis thioredoxin glutathione reductase 0.0029 0.0874 0.2496
Mycobacterium ulcerans esterase/lipase LipP 0.0036 0.1174 1
Trypanosoma brucei PAB1-binding protein , putative 0.0025 0.0674 0.1924
Plasmodium falciparum thioredoxin reductase 0.0029 0.0874 0.2496
Mycobacterium leprae Probable lipase LipE 0.0036 0.1174 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.2 uM Inhibition of HCV NS5B J4 delta 21 polymerase ChEMBL. 17270443

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.